All-cause mortality in the cohorts of the Spanish AIDS Research Network (RIS) compared with the general population: 1997-2010

BMC Infectious Diseases

Volumn 13, Issue 1, 2013, Pages

  Hernando, Victoria ^a,b   Alejos, Belen ^a,b   Monge, Susana ^a,b   Berenguer, Juan ^c   Anta, Lourdes ^d   Vinuesa, David ^e   Palacios, Rosario ^f   Muga, Roberto ^g   Moreno, Santiago ^h   Jarrin, Inma ^a,b  

^a CARLOS III INSTITUTE OF HEALTH   (Spain)

^b CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^c HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^d HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^e HOSPITAL UNIVERSITARIO SAN CECILIO   (Spain)

^f HOSPITAL UNIVERSITARIO VIRGEN DE LA VICTORIA   (Spain)

^g HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^h HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

Excess mortality; HIV infection; Mortality rate; Standardized mortality ratios

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; EXCESS MORTALITY RATE; FEMALE; FOLLOW UP; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; MORTALITY; SPAIN; STANDARDIZED MORTALITY RATIO;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; COHORT STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; SPAIN; YOUNG ADULT;

EID: 84884200063     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-13-382     Document Type: Article

References (23)

1. Krentz HB, Kliewer G, Gill MJ. Changing mortality rates and causes of death for HIV-infected individuals living in Southern Alberta, Canada from 1984 to 2003. HIV Med 2005, 6:99-106. 10.1111/j.1468-1293.2005.00271.x, 15807715.
2. Palella FJ, Baker RK, Moorman AC, Chmiel JS, Wood KC, Brooks JT, Holmberg SD. Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study. J Acquir Immune Defic Syndr 2006, 43:27-34. 10.1097/01.qai.0000233310.90484.16, 16878047.
3. Jaggy C, Von Overbeck J, Ledergerber B, Schwarz C, Egger M, Rickenbach M, Furrer HJ, Telenti A, Battegay M, Flepp M, et al. Mortality in the Swiss HIV Cohort Study (SHCS) and the Swiss general population. Lancet 2003, 362:877-878. 10.1016/S0140-6736(03)14307-3, 13678976.
4. Lewden C, Chene G, Morlat P, Raffi F, Dupon M, Dellamonica P, Pellegrin JL, Katlama C, Dabis F, Leport C. HIV-infected adults with a CD4 cell count greater than 500 cells/mm3 on long-term combination antiretroviral therapy reach same mortality rates as the general population. J Acquir Immune Defic Syndr 2007, 46:72-77. 10.1097/QAI.0b013e3181576818, 17621240.
5. Lohse N, Hansen AB, Pedersen G, Kronborg G, Gerstoft J, Sorensen HT, Vaeth M, Obel N. Survival of persons with and without HIV infection in Denmark, 1995-2005. Ann Intern Med 2007, 146:87-95. 10.7326/0003-4819-146-2-200701160-00003, 17227932.
6. Van Sighem A, Danner S, Ghani AC, Gras L, Anderson RM, De Wolf F. Mortality in patients with successful initial response to highly active antiretroviral therapy is still higher than in non-HIV-infected individuals. J Acquir Immune Defic Syndr 2005, 40:212-218. 10.1097/01.qai.0000165911.97085.d0, 16186740.
7. Causes of death in HIV-1-infected patients treated with antiretroviral therapy, 1996-2006: collaborative analysis of 13 HIV cohort studies. Clin Infect Dis 2010, 50:1387-1396. 3157754, 20380565.
8. Aldaz P, Moreno-Iribas C, Egues N, Irisarri F, Floristan Y, Sola-Boneta J, Martinez-Artola V, Sagredo M, Castilla J. Mortality by causes in HIV-infected adults: comparison with the general population. BMC Public Health 2011, 11:300. 10.1186/1471-2458-11-300, 3112125, 21569323.
9. Martinez E, Milinkovic A, Buira E, De Lazzari E, Leon A, Larrousse M, Lonca M, Laguno M, Blanco JL, Mallolas J, et al. Incidence and causes of death in HIV-infected persons receiving highly active antiretroviral therapy compared with estimates for the general population of similar age and from the same geographical area. HIV Med 2007, 8:251-258. 10.1111/j.1468-1293.2007.00468.x, 17461853.
10. Caro-Murillo AM, Castilla J, Perez-Hoyos S, Miro JM, Podzamczer D, Rubio R, Riera M, Viciana P, Lopez AJ, Iribarren JA, et al. Spanish cohort of naive HIV-infected patients (CoRIS): rationale, organization and initial results. Enferm Infecc Microbiol Clin 2007, 25:23-31. 10.1157/13096749, 17261243.
11. Sobrino-Vegas P, Gutierrez F, Berenguer J, Labarga P, Garcia F, Alejos-Ferreras B, Munoz MA, Moreno S, Del Amo J. [The cohort of the spanish hiv research network (coris) and its associated biobank; organizational issues, main findings and losses to follow-up]. Enferm Infecc Microbiol Clin 2011, 29:645-653. 10.1016/j.eimc.2011.06.002, 21820763.
12. Zwahlen M, Harris R, May M, Hogg R, Costagliola D, De Wolf F, Gill J, Fatkenheuer G, Lewden C, Saag M, et al. Mortality of HIV-infected patients starting potent antiretroviral therapy: comparison with the general population in nine industrialized countries. Int J Epidemiol 2009, 38:1624-1633. 3119390, 19820106.
13. Hernando V, Perez-Cachafeiro S, Lewden C, Gonzalez J, Segura F, Oteo JA, Rubio R, Dalmau D, Moreno S, Amo JD. All-cause and liver-related mortality in HIV positive subjects compared to the general population: differences by HCV co-infection. J Hepatol 2012, 57:743-751. 10.1016/j.jhep.2012.06.010, 22709620.
14. Berenguer J, Alejos B, Hernando V, Viciana P, Salavert M, Santos I, Gomez-Sirvent JL, Vidal F, Portilla J, Del AJ. Trends in mortality according to hepatitis C virus serostatus in the era of combination antiretroviral therapy. AIDS 2012, 26(17):2241-2246. 10.1097/QAD.0b013e3283574e94, 22781223.
15. Chen TY, Ding EL, Seage Iii GR, Kim AY. Meta-analysis: increased mortality associated with hepatitis C in HIV-infected persons is unrelated to HIV disease progression. Clin Infect Dis 2009, 49:1605-1615. 10.1086/644771, 2805261, 19842982.
16. Gutierrez F, Padilla S, Masia M, Iribarren JA, Moreno S, Viciana P, Munoz L, Gomez Sirvent JL, Vidal F, Lopez-Aldeguer J, et al. Clinical outcome of HIV-infected patients with sustained virologic response to antiretroviral therapy: long-term follow-up of a multicenter cohort. PLoS One 2006, 1:e89. 10.1371/journal.pone.0000089, 1762396, 17183720.
17. Perez CS, Del Amo J, Iribarren JA, Salavert LM, Gutierrez F, Moreno A, Labarga P, Pineda JA, Vidal F, Berenguer J, et al. Decrease in serial prevalence of coinfection with hepatitis C virus among HIV-infected patients in Spain, 1997-2006. Clin Infect Dis 2009, 48:1467-1470. 10.1086/598333, 19368502.
18. Ray M, Logan R, Sterne JA, Hernandez-Diaz S, Robins JM, Sabin C, Bansi L, Van Sighem A, De Wolf F, Costagliola D, et al. The effect of combined antiretroviral therapy on the overall mortality of HIV-infected individuals. AIDS 2010, 24:123-137. 2920287, 19770621.
19. Smit C, Geskus R, Walker S, Sabin C, Coutinho R, Porter K, Prins M. Effective therapy has altered the spectrum of cause-specific mortality following HIV seroconversion. AIDS 2006, 20:741-749. 10.1097/01.aids.0000216375.99560.a2, 16514305.
20. Sobrino-Vegas P, Garcia-San Miguel L, Caro-Murillo AM, Miro JM, Viciana P, Tural C, Saumoy M, Santos I, Sola J, Del Amo J, et al. Delayed diagnosis of HIV infection in a multicenter cohort: prevalence, risk factors, response to HAART and impact on mortality. Curr HIV Res 2009, 7:224-230. 10.2174/157016209787581535, 19275591.
21. Lewden C, Bouteloup V, De WS, Sabin C, Mocroft A, Wasmuth JC, Van SA, Kirk O, Obel N, Panos G, et al. All-cause mortality in treated HIV-infected adults with CD4 >/=500/mm3 compared with the general population: evidence from a large European observational cohort collaboration. Int J Epidemiol 2012, 41:433-445.
22. Ministry of Health SPaE Patterns of mortality in Spain, 2008 2011, http://www.mspsi.gob.es/estadEstudios/estadisticas/estadisticas/estMinisterio/mortalidad/mortalidad.htm, Ministry of Health SPaE.
23. Centro Nacional de Epidemiología Vigilancia Epidemiológica del VIH/SIDA en España 2011, http://www.isciii.es/ISCIII/es/contenidos/fd-servicios-cientifico-tecnicos/fd-vigilancias-alertas/fd-enfermedades/Informe_VIH-sida_Junio_2011.pdf, Centro Nacional de Epidemiología.